Search research articles
Contact Us
Filters
Showing results (11-20 of 97) with videos related to
Page
of 10
Sort By:
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
Sequencing of nontransplant treatments in multiple myeloma patients with active disease
Andrew J Yee, Noopur S Raje
Clinical Interventions in Aging
|
September 15, 2012
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
Andrew J Yee, Noopur S Raje
Future Oncology (London, England)
|
October 21, 2017
Denosumab for the treatment of bone disease in solid tumors and multiple myeloma
Andrew J Yee, Noopur S Raje
The New England Journal of Medicine
|
February 21, 2007
CT screening for lung cancer
Andrew J Yee, Thomas J Lynch
The Oncologist
|
February 16, 2018
Panobinostat and Multiple Myeloma in 2018
Andrew J Yee, Noopur S Raje
Current Osteoporosis Reports
|
September 2, 2017
Myeloma and Bone Disease
Cristina Panaroni, Andrew J Yee, Noopur S Raje
Cancers
|
May 17, 2020
Treatment of Smoldering Multiple Myeloma: Ready for Prime Time?
E Bridget Kim, Andrew J Yee, Noopur Raje
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 11, 2014
Advances in supportive care for multiple myeloma
Noopur S Raje, Andrew J Yee, G David Roodman
Ejhaem
|
April 18, 2024
Intravitreal aflibercept confounds interpretation of plasma VEGF (vascular endothelial growth factor) levels in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome
Mary C Boulanger, Marisa G Tieger, Dean Eliott, et al.
Circulation
|
July 8, 2015
Progressive Onset of Extracardiac and Myocardial Symptoms: Right Heart Failure and Cor Pulmonale in a Young Man With Debilitating Polyneuropathy and Monoclonal Gammopathy
Kenta Nakamura, Mary Z Bechis, Andrew J Yee, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 97) with videos related to
Sort By:
Page
of 10
Hematology. American Society of Hematology. Education Program
|
December 4, 2016
Sequencing of nontransplant treatments in multiple myeloma patients with active disease
Andrew J Yee, Noopur S Raje
Clinical Interventions in Aging
|
September 15, 2012
Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
Andrew J Yee, Noopur S Raje
Future Oncology (London, England)
|
October 21, 2017
Denosumab for the treatment of bone disease in solid tumors and multiple myeloma
Andrew J Yee, Noopur S Raje
The New England Journal of Medicine
|
February 21, 2007
CT screening for lung cancer
Andrew J Yee, Thomas J Lynch
The Oncologist
|
February 16, 2018
Panobinostat and Multiple Myeloma in 2018
Andrew J Yee, Noopur S Raje
Current Osteoporosis Reports
|
September 2, 2017
Myeloma and Bone Disease
Cristina Panaroni, Andrew J Yee, Noopur S Raje
Cancers
|
May 17, 2020
Treatment of Smoldering Multiple Myeloma: Ready for Prime Time?
E Bridget Kim, Andrew J Yee, Noopur Raje
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 11, 2014
Advances in supportive care for multiple myeloma
Noopur S Raje, Andrew J Yee, G David Roodman
Ejhaem
|
April 18, 2024
Intravitreal aflibercept confounds interpretation of plasma VEGF (vascular endothelial growth factor) levels in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome
Mary C Boulanger, Marisa G Tieger, Dean Eliott, et al.
Circulation
|
July 8, 2015
Progressive Onset of Extracardiac and Myocardial Symptoms: Right Heart Failure and Cor Pulmonale in a Young Man With Debilitating Polyneuropathy and Monoclonal Gammopathy
Kenta Nakamura, Mary Z Bechis, Andrew J Yee, et al.
Page
of 10